Considerations for coverage of digital therapeutics
What role should digital therapeutics (DTx) play in our treatment landscape? What regulatory and access processes need to be established to be sure these treatments are safe, effective and high value? What evidence is needed to support claims of safety, efficacy and value? These questions and more were tackled as part of an AMCP Partnership…